EDGAR Filing Documents for 0001126234-15-000118

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001126234-15-000118

Filing Date

2015-06-25

Accepted

2015-06-25 17:25:57

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	nlnk-20150625xs3.htm	S-3	428741
2	EXHIBIT 4.3	nlnk-20150625xs3xex43.htm	EX-4.3	375583
3	EXHIBIT 4.4	nlnk-20150625xs3xex44.htm	EX-4.4	202496
4	EXHIBIT 4.5	nlnk-20150625xs3xex45.htm	EX-4.5	199081
5	EXHIBIT 4.6	nlnk-20150625xs3xex46.htm	EX-4.6	185773
6	EXHIBIT 5.1	nlnk-20150625xs3xex51.htm	EX-5.1	25117
7	EXHIBIT 12.1	nlnk-20150625xs3xex121.htm	EX-12.1	38347
8	EXHIBIT 23.1	nlnk-20150625xs3xex231.htm	EX-23.1	3027
9	LOGO	hireslogoimage1.gif	GRAPHIC	8108
10	GRAPHIC	nlnk20121227ex511.jpg	GRAPHIC	30384
	Complete submission text file	0001126234-15-000118.txt		1512453

Mailing Address 2503 SOUTH LOOP DRIVE SUITE 5100 AMES IA 50010

Business Address 2503 SOUTH LOOP DRIVE SUITE 5100 AMES IA 50010 515-296-5555

NEWLINK GENETICS CORP (Filer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-205234 | Film No.: 15952547
SIC: 2834 Pharmaceutical Preparations